Physician profile
Julianne Smith
NPI 1871130260
$880.18
in general payments reported to CMS, 2019-2025
20 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.08 · 2022: $165 · 2023: $251 · 2024: $315 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $148.31 | 2024-2025 | Azstarys |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Gemtesa |
| Novo Nordisk INC | $124.92 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $63.85 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $53.76 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $51.24 | 2023 | Dupixent |
| Insulet Corporation | $48.48 | 2021-2023 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $37.95 | 2025 | Elaprase |
| Sanofi-Aventis U.S. LLC | $36.53 | 2024 | |
| Tris Pharma INC | $22.99 | 2024 | Dyanavel Xr |
| Novartis Pharmaceuticals Corporation | $22.34 | 2023 | |
| Sanofi Pasteur INC. | $21.75 | 2024 | |
| Dexcom, INC. | $21.30 | 2022 | |
| Idorsia Pharmaceuticals US INC | $18.52 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $15.09 | 2024 | Rotarix, Bexsero, Pediarix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.98 | 2024 | Doc Band |
| Collegium Pharmaceutical, INC. | $14.04 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $13.38 | 2022 | |
| Ironwood Pharmaceuticals, INC | $13.28 | 2024 | |
| Paratek Pharmaceuticals, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julianne Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.